AAV-Based Gene Therapy for the Long-Term Treatment of CLN2-Associated Retinal Degeneration and Prevention of Blindness in CLN2 Patients Grant uri icon

Overview

date/time interval

  • May 3, 2021 - May 2, 2023

sponsor award ID

  • BP 214968-01

Affiliation